238 related articles for article (PubMed ID: 31730822)
1. Citrullination of fibrinogen by peptidylarginine deiminase 2 impairs fibrin clot structure.
Damiana T; Damgaard D; Sidelmann JJ; Nielsen CH; de Maat MPM; Münster AB; Palarasah Y
Clin Chim Acta; 2020 Feb; 501():6-11. PubMed ID: 31730822
[TBL] [Abstract][Full Text] [Related]
2. Citrullinated fibrinogen shows defects in FPA and FPB release and fibrin polymerization catalyzed by thrombin.
Okumura N; Haneishi A; Terasawa F
Clin Chim Acta; 2009 Mar; 401(1-2):119-23. PubMed ID: 19109936
[TBL] [Abstract][Full Text] [Related]
3. Relative efficiencies of peptidylarginine deiminase 2 and 4 in generating target sites for anti-citrullinated protein antibodies in fibrinogen, alpha-enolase and histone H3.
Damgaard D; Bawadekar M; Senolt L; Stensballe A; Shelef MA; Nielsen CH
PLoS One; 2018; 13(8):e0203214. PubMed ID: 30161253
[TBL] [Abstract][Full Text] [Related]
4. High-Titer Rheumatoid Arthritis Antibodies Preferentially Bind Fibrinogen Citrullinated by Peptidylarginine Deiminase 4.
Blachère NE; Parveen S; Frank MO; Dill BD; Molina H; Orange DE
Arthritis Rheumatol; 2017 May; 69(5):986-995. PubMed ID: 28029744
[TBL] [Abstract][Full Text] [Related]
5. The roles of PAD2- and PAD4-mediated protein citrullination catalysis in cancers.
Wang Y; Chen R; Gan Y; Ying S
Int J Cancer; 2021 Jan; 148(2):267-276. PubMed ID: 33459350
[TBL] [Abstract][Full Text] [Related]
6. Demonstration of extracellular peptidylarginine deiminase (PAD) activity in synovial fluid of patients with rheumatoid arthritis using a novel assay for citrullination of fibrinogen.
Damgaard D; Senolt L; Nielsen MF; Pruijn GJ; Nielsen CH
Arthritis Res Ther; 2014 Dec; 16(6):498. PubMed ID: 25475141
[TBL] [Abstract][Full Text] [Related]
7. Citrullinated fibrinogen inhibits thrombin-catalysed fibrin polymerization.
Nakayama-Hamada M; Suzuki A; Furukawa H; Yamada R; Yamamoto K
J Biochem; 2008 Sep; 144(3):393-8. PubMed ID: 18583356
[TBL] [Abstract][Full Text] [Related]
8. Citrullinated fibrinogen forms densely packed clots with decreased permeability.
Varjú I; Tóth E; Farkas ÁZ; Farkas VJ; Komorowicz E; Feller T; Kiss B; Kellermayer MZ; Szabó L; Wacha A; Bóta A; Longstaff C; Kolev K
J Thromb Haemost; 2022 Dec; 20(12):2862-2872. PubMed ID: 36083779
[TBL] [Abstract][Full Text] [Related]
9. Citrulline Not a Major Determinant in the Recognition of Peptidylarginine Deiminase 2 and 4 by Autoantibodies in Rheumatoid Arthritis.
Darrah E; Davis RL; Curran AM; Naik P; Chen R; Na CH; Giles JT; Andrade F
Arthritis Rheumatol; 2020 Sep; 72(9):1476-1482. PubMed ID: 32255561
[TBL] [Abstract][Full Text] [Related]
10. Peptidylarginine deiminase 2 is required for tumor necrosis factor alpha-induced citrullination and arthritis, but not neutrophil extracellular trap formation.
Bawadekar M; Shim D; Johnson CJ; Warner TF; Rebernick R; Damgaard D; Nielsen CH; Pruijn GJM; Nett JE; Shelef MA
J Autoimmun; 2017 Jun; 80():39-47. PubMed ID: 28188029
[TBL] [Abstract][Full Text] [Related]
11. Potential protein targets of the peptidylarginine deiminase 2 and peptidylarginine deiminase 4 enzymes in rheumatoid synovial tissue and its possible meaning.
Badillo-Soto MA; Rodríguez-Rodríguez M; Pérez-Pérez ME; Daza-Benitez L; Bollain-Y-Goytia JJ; Carrillo-Jiménez MA; Avalos-Díaz E; Herrera-Esparza R
Eur J Rheumatol; 2016 Jun; 3(2):44-49. PubMed ID: 27708970
[TBL] [Abstract][Full Text] [Related]
12. Impact of fibrinogen carbamylation on fibrin clot formation and stability.
Binder V; Bergum B; Jaisson S; Gillery P; Scavenius C; Spriet E; Nyhaug AK; Roberts HM; Chapple ILC; Hellvard A; Delaleu N; Mydel P
Thromb Haemost; 2017 May; 117(5):899-910. PubMed ID: 28382370
[TBL] [Abstract][Full Text] [Related]
13. Expanding the citrullinome of synovial fibrinogen from rheumatoid arthritis patients.
Sharma M; Damgaard D; Senolt L; Svensson B; Bay-Jensen AC; Nielsen CH; Hägglund P
J Proteomics; 2019 Sep; 208():103484. PubMed ID: 31408709
[TBL] [Abstract][Full Text] [Related]
14. Applicability of Small-Molecule Inhibitors in the Study of Peptidyl Arginine Deiminase 2 (PAD2) and PAD4.
Martín Monreal MT; Rebak AS; Massarenti L; Mondal S; Šenolt L; Ødum N; Nielsen ML; Thompson PR; Nielsen CH; Damgaard D
Front Immunol; 2021; 12():716250. PubMed ID: 34737738
[TBL] [Abstract][Full Text] [Related]
15. Generation of Distinct Patterns of Rheumatoid Arthritis Autoantigens by Peptidylarginine Deiminase Types 2 and 4 During Perforin-Induced Cell Damage.
Romero V; Darrah E; Andrade F
Arthritis Rheumatol; 2020 Jun; 72(6):912-918. PubMed ID: 31876120
[TBL] [Abstract][Full Text] [Related]
16. PAD2-mediated citrullination of Fibulin-5 promotes elastogenesis.
Sun B; Tomita B; Salinger A; Tilvawala RR; Li L; Hakami H; Liu T; Tsoyi K; Rosas IO; Reinhardt DP; Thompson PR; Ho IC
Matrix Biol; 2021 Aug; 102():70-84. PubMed ID: 34274450
[TBL] [Abstract][Full Text] [Related]
17. Decreased plasmin resistance by clots of a homophenotypic Aalpha R 16H fibrinogen (Kingsport, slower fibrinopeptide A than fibrinopeptide B release).
Galanakis DK; Neerman-Arbez M; Kudryk B; Henschen A
Blood Coagul Fibrinolysis; 2010 Mar; 21(2):135-9. PubMed ID: 20019599
[TBL] [Abstract][Full Text] [Related]
18. PAD-2-mediated citrullination of nucleophosmin provides an effective target for tumor immunotherapy.
Choudhury RH; Symonds P; Paston SJ; Daniels I; Cook KW; Gijon M; Metheringham RL; Brentville VA; Durrant LG
J Immunother Cancer; 2022 Feb; 10(2):. PubMed ID: 35140112
[TBL] [Abstract][Full Text] [Related]
19. Detection of Citrullinated Fibrin in Plasma Clots of Rheumatoid Arthritis Patients and Its Relation to Altered Structural Clot Properties, Disease-Related Inflammation and Prothrombotic Tendency.
Bezuidenhout JA; Venter C; Roberts TJ; Tarr G; Kell DB; Pretorius E
Front Immunol; 2020; 11():577523. PubMed ID: 33424834
[TBL] [Abstract][Full Text] [Related]
20. Reciprocal regulation of Th2 and Th17 cells by PAD2-mediated citrullination.
Sun B; Chang HH; Salinger A; Tomita B; Bawadekar M; Holmes CL; Shelef MA; Weerapana E; Thompson PR; Ho IC
JCI Insight; 2019 Nov; 4(22):. PubMed ID: 31723060
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
